What's your number? http://petardas.in.net/ petardas porno Sarepta on Wednesday said the U.S. Food and Drug Administration did not commit to accepting that production of dystrophin could be considered proof enough of eteplirsen's effectiveness. Some analysts pointed to this ambiguity as the main reason for the share fall.